首季全球智能手机出货量升27% 小米(01810.HK)出货量升62%市占第三
调查机构Canalys发表的报告指,今年首季全球智能手机出货量升27%至3.47亿台,其中三星出货量达7,650万台,市占率22%排名全球第一;苹果(AAPL.US)出货量达5,240万台,市占率15%排全球第二,虽然iPhone 12 Mini销售差过预期,不过iPhone 12其他款式和旧款iPhone 11需求强劲,助苹果维持势头。期内小米(01810.HK)录单季最好表现,期内出货量增62%至4,900万台,市占率14%排全球第三。
期内Oppo及Vivo出货量分别为3,760万台及3,600万台,由於华为不再计及荣耀,故出货量仅1,860万台排全球第七。(el/u) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.